Evidence map›Paper›PMID 38972963›Full record

ArticleEuropean journal of human genetics : EJHG2024

Using a new analytic approach for genotyping and phenotyping chromosome 9p deletion syndrome.

Rodrigo Tzovenos Starosta, Nathaniel Jensen, Sophia Couteranis, Rachel Slaugh, Dawn Easterlin, Victoria Tate, Eleanor I Sams, Kostandin Valle, Titilope Akinwe, Ying-Chen Claire Hou and 4 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic technologies identify milder presentations of Mendelian disease.European journal of human genetics : EJHG · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rodrigo Tzovenos StarostaDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA. Rodrigo.starosta@ufrgs.br.ORCID 0000-0002-2350-7192
Nathaniel JensenDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Sophia CouteranisDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Rachel SlaughDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Dawn EasterlinDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Victoria TateDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Eleanor I SamsDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Kostandin ValleDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0009-0009-2386-0357
Titilope AkinweDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Ying-Chen Claire HouDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Tychele N TurnerDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0001-8246-6477
F Sessions ColeDivision of Newborn Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.
Jeffrey MilbrandtDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Patricia DicksonDivision of Genetics and Genomic Medicine, Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, 63110, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using a new analytic method ("unique non-overlapping region" (UNOR) analysis), we characterized the genotypes and phenotypes of a large cohort of individuals diagnosed with chromosome 9p deletion syndrome (9PMS) and defined critical genomic regions. We extracted phenotypic information from 48 individuals with 9PMS from medical records and used a guided interview with caregivers to clarify ambiguities. Using high-resolution whole-genome sequencing for breakpoint definition, we aligned deletions and drew virtual breakpoints to obtain UNORs associated with phenotypic characteristics. We next extracted genotype and phenotype data for 57 individuals identified from a systematic review of the 9PMS literature and analyzed these as above. Common phenotypic features included developmental delay/intellectual disability, dysmorphic features, hypotonia, genital defects in XY individuals, psychiatric diagnoses, chronic constipation, atopic disease, vision problems, autism spectrum disorder, gastroesophageal reflux disease, trigonocephaly, congenital heart disease, and neonatal hypoglycemia. Our approach confirmed previous literature reports of an association of FREM1 with trigonocephaly and suggested a possible modifier element for this phenotype. In conclusion, the UNOR approach delineated phenotypic characteristics for 9PMS and confirmed the critical role of FREM1 and a possible long-distance regulatory element in pathogenesis of trigonocephaly that will need to be replicated in future studies.

Indexed as

Chromosome DeletionChromosome DisordersChromosomes, Human, Pair 9Intellectual DisabilityPhenotypeAdolescentAdultChildChild, PreschoolDevelopmental DisabilitiesFemaleGenotypeHumansInfantMale

Identifiers

PMID38972963
PMCPMC11369271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.